Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

NCT00426049 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

484

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Coronary Restenosis

Interventions

DRUG: Everolimus

Sponsor

German Heart Institute

Collaborators

[object Object]